Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs.

Expert opinion on drug metabolism & toxicology - 1 Jun 2008

Jänis Minna T, Laaksonen Reijo, Oresic Matej

Abstract excerpt

BACKGROUND: The number of patients eligible for cardiovascular therapies in general is forecast to increase substantially in the coming decades. However, the current list of potential future cardiovascular blockbuster drugs is alarmingly short. There is thus a clear need for innovative strategies to increase the efficiency of drug development pipelines by establishing new sensitive biomarkers to monitor drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Pharmacological
Share to Cardiovascular Agents
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Lipid Metabolism

Share to Phenotype

Share to Treatment Outcome

Source

Identifiers

PMID: 18611110
DOI: 10.1517/17425255.4.6.665

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs.PMID 18611110Read ↗

Metabolomic strategies to study lipotoxicity in cardiovascular diseaseSemantic proximity Read ↗

Metabolomics: a global biochemical approach to drug response and disease.Semantic proximity Read ↗

Integrated untargeted/targeted metabolomics identifies a putative oxylipin signature in patients with atrial fibrillation and coronary heart diseaseSemantic proximity Read ↗

Genomics of lipid metabolism : identification of genetic determinants of lipid metabolites and the effect of perturbations of lipid levels on coronary heart disease risk factorsSemantic proximity Read ↗

Novel and future lipid-modulating therapies for the prevention of cardiovascular diseaseSemantic proximity Read ↗

Metabolomics as a Functional Genomic Tool for Understanding Lipid Dysfunction in Diabetes, Obesity and Related DisordersSemantic proximity Read ↗

Proteomics and metabolomics combined in cardiovascular research.Semantic proximity Read ↗

Human metabolomics: strategies to understand biology.Semantic proximity Read ↗

Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.Semantic proximity Read ↗

[Pharmacogenomics for cardiovascular drugs].Semantic proximity Read ↗

Pharmacometabolomics reveals racial differences in response to atenolol treatment.Semantic proximity Read ↗

Metabolomic signatures of lipid-modifying therapies using drug target Mendelian randomizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.